A new allergic rhinitis therapy (MP29‐02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies. Issue 4 (26th June 2015) - Hellings, Peter; Bachert, Claus; Mösges, Ralph; Scadding, Glenis; Munzel, Ullrich; Fokkens, Wytske